The Filings Report

Incyte Genomics Inc insider trading

INCYfinancial statementsForm 4 filings on EDGAR299 transactions since Nov 1, 2024

From August 4, 2026 to November 1, 2026, 0 insiders at Incyte Genomics Inc bought $0 of stock in the open market, and 2 sold $7M. Officers and directors accounted for $0 of purchases and $7M of sales. The last reported transaction was an option exercise by Cagnoni Pablo J on October 15, 2026.

The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 19, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.

Stock price and insider activity

Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.

INCY daily priceSplit-adjusted prices in US dollars

Bought $0Sold $7MAug 4, 2026 – Nov 1, 2026

Oct 30, 2026O $120.10 · H $122.87 · L $119.55 · C $120.39Bought $0 (0)Sold $0 (0)
$106$113$119$126$1322026-08-04: open $119.08, high $120.93, low $117.00, close $120.602026-08-05: open $123.99, high $124.57, low $119.52, close $119.802026-08-06: open $119.80, high $120.29, low $115.77, close $118.382026-08-07: open $118.56, high $120.88, low $117.38, close $120.562026-08-10: open $120.56, high $122.69, low $120.50, close $121.552026-08-11: open $121.13, high $122.28, low $120.06, close $121.072026-08-12: open $119.54, high $121.57, low $118.88, close $120.772026-08-13: open $122.23, high $122.23, low $119.71, close $120.522026-08-14: open $119.15, high $120.44, low $117.56, close $120.162026-08-17: open $120.16, high $124.06, low $119.64, close $123.502026-08-18: open $124.29, high $124.74, low $123.23, close $123.472026-08-19: open $125.00, high $129.56, low $124.60, close $128.472026-08-20: open $127.10, high $129.80, low $126.71, close $127.222026-08-21: open $126.45, high $129.92, low $125.60, close $127.812026-08-24: open $127.47, high $128.36, low $126.31, close $127.982026-08-25: open $128.98, high $130.80, low $127.50, close $129.722026-08-26: open $129.18, high $129.54, low $127.77, close $128.122026-08-27: open $128.13, high $128.20, low $126.06, close $127.742026-08-28: open $127.74, high $127.74, low $123.08, close $124.372026-08-31: open $122.66, high $124.00, low $121.61, close $123.222026-09-01: open $124.61, high $125.14, low $122.50, close $125.012026-09-02: open $126.43, high $129.56, low $125.89, close $128.832026-09-03: open $129.67, high $130.00, low $126.20, close $128.002026-09-04: open $126.46, high $128.08, low $126.04, close $126.752026-09-08: open $124.11, high $126.40, low $122.22, close $124.402026-09-09: open $125.66, high $127.72, low $123.57, close $126.012026-09-10: open $125.09, high $126.31, low $122.58, close $123.282026-09-11: open $124.35, high $124.35, low $121.42, close $121.472026-09-14: open $122.48, high $123.35, low $121.28, close $122.192026-09-15: open $121.58, high $122.19, low $119.97, close $121.742026-09-16: open $121.48, high $124.96, low $121.48, close $124.752026-09-17: open $125.74, high $127.74, low $125.10, close $127.622026-09-18: open $127.85, high $128.72, low $125.23, close $125.312026-09-21: open $125.00, high $127.41, low $124.19, close $124.652026-09-22: open $124.72, high $127.75, low $124.01, close $126.932026-09-23: open $127.51, high $128.17, low $123.89, close $124.642026-09-24: open $124.79, high $125.55, low $123.03, close $124.442026-09-25: open $125.72, high $126.00, low $123.07, close $123.892026-09-28: open $123.32, high $126.14, low $122.53, close $124.822026-09-29: open $123.67, high $125.47, low $121.89, close $123.202026-09-30: open $123.00, high $124.23, low $121.03, close $121.352026-10-01: open $120.47, high $121.22, low $117.03, close $117.142026-10-02: open $116.76, high $117.19, low $114.57, close $115.302026-10-05: open $115.15, high $115.67, low $112.83, close $114.132026-10-06: open $114.13, high $114.97, low $111.67, close $112.732026-10-07: open $112.82, high $115.49, low $112.46, close $113.442026-10-08: open $112.89, high $113.75, low $110.08, close $112.752026-10-09: open $112.35, high $113.87, low $111.81, close $112.792026-10-12: open $114.05, high $114.05, low $111.26, close $111.362026-10-13: open $111.29, high $111.68, low $107.78, close $108.622026-10-14: open $108.61, high $112.06, low $107.83, close $111.572026-10-15: open $112.71, high $116.03, low $112.60, close $113.272026-10-16: open $113.98, high $114.57, low $112.02, close $113.072026-10-19: open $113.19, high $114.38, low $112.71, close $113.252026-10-20: open $113.78, high $117.00, low $113.26, close $116.622026-10-21: open $115.98, high $116.57, low $113.35, close $113.442026-10-22: open $113.93, high $117.17, low $112.76, close $116.932026-10-23: open $116.75, high $116.87, low $115.12, close $115.712026-10-26: open $115.49, high $115.93, low $112.75, close $113.312026-10-27: open $111.18, high $116.76, low $111.18, close $116.602026-10-28: open $115.50, high $118.49, low $114.74, close $116.872026-10-29: open $111.64, high $117.09, low $111.01, close $116.802026-10-30: open $120.10, high $122.87, low $119.55, close $120.39Insider purchases / sales · USD$5M$0−$5M2026-08-05: 0 purchases ($0), 2 sales ($2M)2026-08-12: 0 purchases ($0), 1 sales ($1M)2026-08-19: 0 purchases ($0), 1 sales ($1M)2026-09-15: 0 purchases ($0), 2 sales ($3M)2026-10-15: 0 purchases ($0), 1 sales ($298K)Aug 4Aug 26Sep 17Oct 9Oct 30

purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.

Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.

Every transaction

299 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 15, 2026Cagnoni Pablo JPresident, Global Head of R&Doption exercise839$71.93$60K184,039Oct 19, 2026
Oct 15, 2026Cagnoni Pablo JPresident, Global Head of R&Doption exercise423$61.76$26K184,462Oct 19, 2026
Oct 15, 2026Cagnoni Pablo JPresident, Global Head of R&Doption exercise455$61.18$28K184,917Oct 19, 2026
Oct 15, 2026Cagnoni Pablo JPresident, Global Head of R&Doption exercise925$64.25$59K185,842Oct 19, 2026
Oct 15, 2026Cagnoni Pablo JPresident, Global Head of R&Dopen-market sale10b5-12,642$112.71$298K183,200Oct 19, 2026
Oct 1, 2026Heeson LeeEVP, Head of Incyte Intltax withholding463$117.14$54K37,578Oct 5, 2026
Sep 30, 2026Baker BROS. Advisors LP+5 moreDirector, 10% ownerawardindirect322$0.00—3MOct 2, 2026
Sep 30, 2026Baker BROS. Advisors LP+5 moreDirector, 10% ownerawardindirect322$0.00—28MOct 2, 2026
Sep 30, 2026Clancy Paul JDirectoraward203$121.35$25K25,838Oct 2, 2026
Sep 30, 2026Harrigan EdmundDirectoraward206$121.35$25K23,225Oct 2, 2026
Sep 22, 2026Gardner David HEVP, Chief Strategy Officertax withholding920$126.93$117K15,904Sep 24, 2026
Sep 15, 2026Cagnoni Pablo JPresident, Global Head of R&Doption exercise2,957$61.76$183K186,157Sep 17, 2026
Sep 15, 2026Cagnoni Pablo JPresident, Global Head of R&Doption exercise4,551$61.18$278K190,708Sep 17, 2026
Sep 15, 2026Cagnoni Pablo JPresident, Global Head of R&Doption exercise6,477$64.25$416K197,185Sep 17, 2026
Sep 15, 2026Cagnoni Pablo JPresident, Global Head of R&Doption exercise9,233$71.93$664K206,418Sep 17, 2026
Sep 15, 2026Cagnoni Pablo JPresident, Global Head of R&Dopen-market sale10b5-19,233$120.50$1M197,185Sep 17, 2026
Sep 15, 2026Cagnoni Pablo JPresident, Global Head of R&Dopen-market sale10b5-113,985$120.49$2M183,200Sep 17, 2026
Aug 25, 2026Basi Ramitpal KEVP, Human Resourcestax withholding504$129.72$65K10,993Aug 27, 2026
Aug 19, 2026Cagnoni Pablo JPresident, Global Head of R&Dopen-market sale10b5-110,801$125.56$1M183,200Aug 20, 2026
Aug 12, 2026Cagnoni Pablo JPresident, Global Head of R&Dopen-market sale10b5-110,803$120.04$1M194,001Aug 14, 2026
Aug 5, 2026Cagnoni Pablo JPresident, Global Head of R&Dopen-market sale10b5-110,640$122.69$1M204,804Aug 7, 2026
Aug 5, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise2,207$106.47$235K63,648Aug 7, 2026
Aug 5, 2026Mayes Patrick AEVP & Chief Scientific Officeropen-market sale10b5-12,207$123.99$274K61,441Aug 7, 2026
Aug 3, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise6,055$105.43$638K67,496Aug 4, 2026
Aug 3, 2026Mayes Patrick AEVP & Chief Scientific Officeropen-market sale10b5-16,055$120.43$729K61,441Aug 4, 2026
Jul 31, 2026Cagnoni Pablo JPresident, Global Head of R&Dopen-market sale10b5-115,888$119.70$2M215,444Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise2,918$61.18$179K66,546Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise2,284$64.25$147K68,830Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise2,709$61.76$167K71,539Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise3,148$68.62$216K74,687Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise2,072$71.93$149K76,759Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise9,459$72.27$684K86,218Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise2,623$74.78$196K88,841Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise2,864$77.67$222K91,705Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise1,643$80.50$132K93,348Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise3,023$83.20$252K96,371Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise2,623$83.58$219K98,994Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise1,642$85.01$140K100,636Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise2,293$90.56$208K102,929Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise85$106.47$9K103,014Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeroption exercise326$105.43$34K103,340Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeropen-market sale10b5-114,661$119.46$2M88,679Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeropen-market sale10b5-15,332$119.42$637K83,347Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeropen-market sale10b5-12,187$119.47$261K81,160Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeropen-market sale10b5-16,171$119.43$737K74,989Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeropen-market sale10b5-14,695$119.39$561K70,294Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeropen-market sale10b5-12,864$119.40$342K67,430Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeropen-market sale10b5-11,643$119.51$196K65,787Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeropen-market sale10b5-11,642$119.38$196K64,145Aug 4, 2026
Jul 31, 2026Mayes Patrick AEVP & Chief Scientific Officeropen-market sale10b5-185$122.19$10K64,060Aug 4, 2026

Who the insiders are

Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.

InsiderRoleLast transactionKindShares heldBought, 12 monthsSold, 12 monthsSales under a plan
Hoppenot HerveSpecial Advisor to the CEO, DirectorDec 8, 2025tax withholding326,803—$20M (1)1 of 1
Cagnoni Pablo JPresident, Global Head of R&DOct 15, 2026option exercise184,039—$14M (10)10 of 10
Stein Steven HCMO & Head of Late-Stage Dev.Jul 16, 2026open-market sale21,118—$8M (6)6 of 6
Mayes Patrick AEVP & Chief Scientific OfficerAug 5, 2026option exercise63,648—$7M (15)15 of 15
Morrissey Michael JamesEVP, Head of Tech. OperationsFeb 2, 2026tax withholding34,065—$6M (3)3 of 3
Clancy Paul JDirectorSep 30, 2026award25,838—$1M (1)1 of 1
Issa Mohamed KhairieEVP, Head of U.S. CommercialJul 16, 2026open-market sale63,940—$1M (2)2 of 2
Tray ThomasPrincipal Accounting OfficerJul 16, 2026award21,699—$879K (6)6 of 6
Heeson LeeEVP, Head of Incyte IntlOct 1, 2026tax withholding37,578—$289K (1)1 of 1
Denton Sheila A.EVP & General CounselNov 17, 2025option exercise26,847—$90K (2)2 of 2
Flannelly Barry PEVP & General Manager USJul 16, 2025open-market sale35,149———
Iyengar Vijay KEVP, GMAPPSJul 16, 2025open-market sale40,540———
Baker BROS. Advisors LPDirector, 10% ownerSep 30, 2026award————
Harrigan EdmundDirectorSep 30, 2026award23,225———
Swain Paula JEVP, Human ResourcesJul 15, 2025tax withholding100,052———
Stamoulis ChristianaEVP & Chief Financial OfficerJul 15, 2025tax withholding114,652———
Baker FelixDirector, 10% ownerDec 31, 2025award————
Meury WilliamChief Executive Officer, DirectorJul 16, 2026award183,129———
Bienaime Jean JacquesDirectorJun 8, 2026award24,424———
Trotta MatteoEVP, GM, Dermatology USMar 25, 2026tax withholding14,882———
Baker Brothers Life Sciences LPDirector, 10% ownerJun 30, 2025award————
Gardner David HEVP, Chief Strategy OfficerSep 22, 2026tax withholding15,904———
Basi Ramitpal KEVP, Human ResourcesAug 25, 2026tax withholding10,993———
Hoffman Richard A.EVP & General CounselJul 16, 2026award16,861———
Fouse Jacqualyn ADirectorJun 8, 2026award20,968———
High Katherine ADirectorJun 8, 2026award14,983———
Brawley Otis WDirectorJun 8, 2026award12,894———
Schaffert SusanneDirectorJun 10, 2025award7,389———
667, L.P.Director, 10% ownerMar 31, 2025award————
Upadhyay SuketuEVP & Chief Financial OfficerMay 4, 2026award26,343———

Questions

Are Incyte Genomics Inc insiders buying or selling?

Over the twelve months to November 1, 2026, 10 insiders at Incyte Genomics Inc sold $58M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $58M. Only open-market purchases and sales are counted.

Who sold the most Incyte Genomics Inc stock in the last year?

Hoppenot Herve (Director) sold $20M in 1 open-market sale over the twelve months to November 1, 2026.

Do Incyte Genomics Inc executives sell under 10b5-1 plans?

47 of the 47 open-market sales in the last twelve months (100%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.

What counts as insider buying here?

Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.

More on Incyte Genomics Inc

From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.